GE HealthCare Technologies Earnings Preview: What to Expect

Core Insights - GE HealthCare Technologies Inc. (GEHC) is valued at $34 billion and holds a leading market share in medical imaging and ultrasound equipment [1] - Analysts predict a profit of $1.05 per share for the third quarter, reflecting a 7.9% decrease from $1.14 per share in the same quarter last year [2] - For fiscal 2025, GEHC is expected to report an EPS of $4.53, a slight increase from $4.49 in fiscal 2024, with a projected 8.4% year-over-year growth to $4.91 in fiscal 2026 [3] Financial Performance - GEHC's stock has declined 17.2% over the past 52 weeks, underperforming the Health Care Select Sector SPDR Fund's 4.8% dip and the S&P 500 Index's 17.4% gain [4] - Following the release of Q2 results, where revenues grew 3.5% year-over-year to $5 billion, GEHC's stock dropped 7.8% despite exceeding earnings expectations [5] - The company's net income for Q2 surged 13.6% year-over-year to $486 million, with an EPS of $1.06 surpassing consensus estimates by 16.5% [5] Market Outlook - GEHC's 2025 margins are expected to face pressure due to high tariffs imposed by the current Federal government on the EU and other Indo-Pacific nations [6] - The consensus rating for GEHC has recently dropped to "Moderate Buy," with 12 "Strong Buys," one "Moderate Buy," and seven "Holds" among 20 analysts [6] - The mean price target for GEHC is $87.31, indicating a potential upside of 16.2% from current price levels [6]